vimarsana.com

Latest Breaking News On - Maha katabi - Page 3 : vimarsana.com

Vera Therapeutics (NASDAQ:VERA) Trading Down 5.9%

Vera Therapeutics (NASDAQ:VERA) Trading Down 5.9%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Raymond-james
Maha-katabi
Capital-partners
Vera-therapeutics-inc
Barclays-plc
Nasdaq
Cantor-fitzgerald
Vanguard-group-inc
Goldman-sachs-group-inc
Vera-therapeutics
Get-free-report
Therapeutics-trading-down

Vera Therapeutics' (VERA) Buy Rating Reiterated at Guggenheim

Vera Therapeutics' (VERA) Buy Rating Reiterated at Guggenheim
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Maha-katabi
Raymond-james
Securities-exchange-commission
Cantor-fitzgerald
Capital-partners
Vanguard-group-inc
Nasdaq
Goldman-sachs-group-inc
Barclays-plc
Vera-therapeutics-inc
Vera-therapeutics
Get-free-report

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Raymond-james
Maha-katabi
Barclays-plc
Capital-partners
Vera-therapeutics-company-profile
Goldman-sachs-group-inc
Nasdaq
Vanguard-group-inc
Vera-therapeutics-inc
Cantor-fitzgerald
Vera-therapeutics
Get-free-report

Vera Therapeutics, Inc. (NASDAQ:VERA) Director Maha Katabi Sells 81,009 Shares

Vera Therapeutics, Inc. (NASDAQ:VERA) Director Maha Katabi Sells 81,009 Shares
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Canada
Maha-katabi
Raymond-james
Nasdaq
Tower-research-capital
Vera-therapeutics-inc
Cantor-fitzgerald
Life-insurance-co
Royal-bank
Jpmorgan-chase-co
Ameritas-investment-partners-inc
Vera-therapeutics

Wedbush Raises Vera Therapeutics (NASDAQ:VERA) Price Target to $34.00

Vera Therapeutics (NASDAQ:VERA – Free Report) had its price objective boosted by Wedbush from $21.00 to $34.00 in a research report sent to investors on Thursday, Benzinga reports. They currently have a neutral rating on the stock. A number of other analysts also recently issued reports on the stock. Raymond James raised shares of Vera […]

Canada
Raymond-james
Maha-katabi
Jpmorgan-chase-co
Securities-exchange-commission
Royal-bank
Cantor-fitzgerald
Life-insurance-co
Ameritas-investment-partners-inc
Vera-therapeutics-inc
Vera-therapeutics
Free-report

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.